Multimodal interpretable data-driven models for early prediction of multidrug resistance using multivariate time
Óscar Escudero-Arnanz1, Sergio Martínez-Agüero1, Paula Martín-Palomeque1
1Department of Signal Theory and Communications, Telematics and Computing Systems, Rey Juan Carlos University, 28942 Fuenlabrada, Spain.
None:
Electronic Health Records (EHRs) serve as a comprehensive repository of multimodal patient health data, combining static demographic attributes with dynamic, irregular Multivariate Time Series (MTS), characterized by varying lengths. While MTS provide critical insights for clinical predictions, their integration with static features enables a more nuanced understanding of patient health trajectories and enhances predictive accuracy. Deep Neural Networks (DNNs) have proven highly effective in capturing complex patterns in healthcare data, offering a framework for multimodal data fusion. However, their adoption in clinical practice is limited by a lack of interpretability, as transparency and explainability are essential for supporting informed medical decisions. This study presents interpretable multimodal DNN architectures for predicting and understanding the emergence of Multidrug Resistance (MDR) in Intensive Care Units (ICUs). The proposed models integrate static demographic data with temporal variables, providing a holistic view of baseline patient characteristics and health progression. To address predictive performance and interpretability challenges, we introduce a novel methodology combining feature selection techniques with attention mechanisms and post-hoc explainability tools. This approach not only reduces feature redundancy but also highlights key risk factors, thereby improving model accuracy and robustness. Experimental results demonstrate the effectiveness of the proposed framework, achieving a Receiver Operating Characteristic Area Under the Curve of 76.90 ± 3.10, a significant improvement over baseline models. Beyond MDR prediction, this methodology offers a scalable and interpretable framework for addressing various clinical challenges involving EHR data. By integrating predictive accuracy with explanatory insights-such as the identification of key risk factors-this work supports timely, evidence-based interventions to improve patient outcomes in ICU settings.
More Related Videos
08:46Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
14:51Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype
Published on: June 17, 2022
Related Concept Videos
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Multicompartment Models: Overview
These models offer a more comprehensive representation of drug behavior in the body than one-compartment models. They accommodate the complexity of drug distribution,...
Analysis of Population Pharmacokinetic Data
Pharmacokinetic Models: Overview
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
Model Approaches for Pharmacokinetic Data: Compartment Models
Two primary types of compartment models are recognized: mammillary and catenary. The more...
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
